Zytiga 250 mg - Abiraterone Acetate

Zytiga 250mg Tablet
Zytiga (abiraterone) works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.

Zytiga 250mg Tablet Uses
Zytiga Abiraterone Acetate 250mg tablet is used in the treatment of prostate cancer.

Side Effects of Zytiga 250mg Tablet
Decreased potassium level in blood, Edema (swelling), Hypersensitivity, Irregular heartbeat, Dizziness, Nausea, Vomiting, Shortness of breath, Anemia, Hypokalemia, Increased blood pressure, Urinary tract infection, Diarrhoea

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.

How to use Zytiga 250mg Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zytiga 250mg Tablet is to be taken empty stomach.

Dosage

Missed Dose
If a dose of Abiraterone is missed, skip the missed dose and continue the normal dosing schedule from the next day. If more than one dose is missed, contact the doctor and follow the instructions of your doctor.

Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Warnings

Pregnancy - This medicine is not recommended for use in women.
Breast-feeding - This medicine is not recommended for use in women.
General warnings
Use in pediatrics - This medicine is not recommended for use in children and adolescents.
Use in females - This medicine is not recommended for use in female patients.
Contraception - Effective contraception methods must be used while on treatment with this medicine and until 1 week after stopping the therapy.

How to Order Zytiga (Abiraterone) 250mg Tablets from India
If you wish to order Zytiga Abiraterone 250mg Tablets online from India at an affordable price, you just have to fill the "ASK Price" form. We will get in touch with you as soon as your order gets placed.

Top